CreatiVasc snags $5M for dialysis tech; MBio teams with NIH for HIV diagnostics;

@FierceMedDev: Oxford University blood test designed to screen for stress. Item | Follow @FierceMedDev

@MarkHFierce: Google is the lead in SynapDx's $15.4M funding round - the trial for its autism Dx blood test is now under way. ICYMI yesterday | Follow @MarkHFierce

 @DamianFierce: The FDA has changed its approach to medical device hackers, part of its new commitment to cybersecurity. Report | Follow @DamianFierce

> CreatiVasc Medical secured a $5 million investment from Brookhaven Medical, cash that will support its Hemoaccess Valve System for dialysis. Release

> MBio Diagnostics secured a $1.4 million federal research grant to advance its work on an early HIV diagnostic test that doesn't need to wait for lab results. Story

> Tyrx, a 2012 Fierce 15 company, won FDA clearance to use its AIGISRx device envelope in implanted nerve stimulators. News

> Beacon Endoscopic raised more than $1.2 million toward developing new tools for endoscopic surgical and treatment procedures. Item

> Alere ($ALR) is making another pitch to shareholders, averring its ability to grow revenue and disputing claims from activist investor Coppersmith Capital Management. More

> Life Technologies' ($LIFE) shareholders will vote Aug. 21 whether to accept Thermo Fisher's ($TMO) $76-a-share buyout offer. Release

> Skylight Healthcare Systems, maker of interactive patient care devices, secured $10 million in term loan financing from GE Capital ($GE). News

> IMRIS ($IMRS) won FDA clearance for the Visius iCT, a first-of-its-kind ceiling-mounted imaging device for spinal and brain surgeries. Release

Biotech News

@FierceBiotech: ICYMI yesterday: First successful transplant of retinas made from embryonic stem cells. Article | Follow @FierceBiotech

 @JohnCFierce: Report: Big Pharma mounts secret attack against data transparency rule (some companies will never learn). ICYMI yesterday | Follow @JohnCFierce

@RyanMFierce: Biogen sees 'unlikely' link between Tecfidera and patient death. Story | Follow @RyanMFierce

> Cytokinetics patches up ALS drug trial after costly study snafu. More

> NYT: GlaxoSmithKline's China R&D audit found ethical breaches. Report

> Array BioPharma scores midstage success for asthma drug. Report

Pharma News

@FiercePharma: Some good news for Forest Labs: Quarterly sales tick up 6% to almost $800M; Forest credits newer products. More | Follow @FiercePharma

 @CarlyHFierce: Former AstraZeneca exec Tony Zook officially in as new CEO of Vivus. News | Follow @CarlyHFierce

> China detains first U.S. citizen in pharma industry probe. Story

> GlaxoSmithKline forges ahead with hunt for Chinese vaccine partners. Article

> Biogen: Tecfidera link to MS patient's death 'unlikely.' Report

Biotech Research News

 @EmilyMFierce: Novartis MS drug prevents heart failure in animal study. Article | Follow @EmilyMFierce

> Retinas made from embryonic stem cells implanted into mice for the first time. News

> New 3-D model of diabetes target could shape drug design. Story

> Neural origins of menopausal hot flashes discovered. Item

> Revalesio drug alters Alzheimer's progression in animal model. Article

Pharma Manufacturing News

 @EricPFierce: Orphan drugs have become a key product for many companies. See why: Special report | Follow @EricPFierce

> Wockhardt FDA warning letter says QA staff tried to mislead inspectors. Report

> Drug shortages in Ireland getting worse. More

> New bill could free drug user fees from sequestration, improve oversight. Article

> Venus Remedies gets 9 Ukraine plants approved. Item

> AMRI gets issues under control at Burlington plant. Report

Sponsored By Metabolon

Five Translational Insights Key to a Successful First-in-Human (FIH) Study – Metabolite-Based Biomarker Discovery and Validation

Translational success rates from pre-clinical animal studies to human clinical trials remain frustratingly low. Learn how metabolomics helps you bridge between the theoretical & practical, between the function & actual activity of your drug molecule to get you closer to the phenotype, sooner.